Atossa Therapeutics (NASDAQ:ATOS – Free Report) was upgraded by equities research analysts at StockNews.com from a “sell” rating to a “hold” rating in a research note issued to investors on Thursday. Atossa Therapeutics Price Performance Shares of Atossa Therapeutics stock traded up $0.11 during trading on Thursday, hitting $1.28. The stock had a trading volume […]
The global data center generator market is expected to grow globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.
2023-06-14 As the third round of participants at the Ratos BELP graduated in June 2023, we asked Jonas Wiström, President and CEO, and Anders Slettengren, EVP and. | June 14, 2023